Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month inte
- PDF / 303,317 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 68 Downloads / 171 Views
CORRECTION
Open Access
Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12month interim analysis of ROCK-J, a postmarketing surveillance study Hidenobu Tanihara1*, Takahiko Kakuda2, Tetsuro Sano2, Takashi Kanno2 and Ryoji Gunji2 Correction to: BMC Ophthalmol 20, 275 (2020) https://doi.org/10.1186/s12886-020-01490-1 Following publication of the original article [1] the authors have notified us of an error in the Fig. 6. The corrected Fig. 6 is presented below: Author details 1 Kumamoto University Hospital, Japan 1-1-1 Honjo, Chuo-ku, Kumamoto, Japan. 2Post Marketing Surveillance Department, Kowa Co., Ltd., Tokyo, Japan.
Reference 1. Tanihara H, et al. Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study. BMC Ophthalmol. 2020;20:275. https:// doi.org/10.1186/s12886-020-01490-1.
The original article can be found online at https://doi.org/10.1186/s12886020-01490-1. * Correspondence: [email protected] 1 Kumamoto University Hospital, Japan 1-1-1 Honjo, Chuo-ku, Kumamoto, Japan Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Tanihara et al. BMC Ophthalmology
(2020) 20:362
Page 2 of 2
Fig. 6 Intraocular pressure and change in intraocular pressure in all patients according to baseline intraocular pressure values. IOP intraocular pressure. a Mean ± standard deviation. b Least-squares mean ± standard error. c Mixed effects model for repeated measures, baseline vs entire post-administration period
Data Loading...
